“The burden of proof has once again shifted to the bears as the algos and the hedge funds seem to be buying every dip,” writes Joe Duarte.

The Clash, a highly popular punk band from the 80s had a big hit with “Should I Stay or Should I go,” a tale of indecision where a guy who can’t seem to figure his girlfriend’s wishes for the evening begs for clarification of his dilemma.

Welcome to the current stock market where investors are experiencing a daily intraday whipsaw as traders, human and algo, try to figure out whether the political stalemate in Washington is more meaningful to asset prices than the fact that the global central banks are not likely to raise interest rates anytime soon.

Historically, we seem to be at that inflection point in the economic cycle where a slowing economy is supposed to affect corporate earnings and the market is looking to the Federal Reserve to lower interest rates. The central bank of China has begun an easing cycle which is having a positive effect on stocks in the Pacific Basin and Asia in general. This is being reflected in the generally positive action in emerging market ETFs.

So, this week with its full schedule of economic data, including Friday’s employment report, a full slate of earnings including Apple (AAPL) and Microsoft (MSFT), and a Fed meeting to start the week, should be an interesting set of trading sessions. Should I stay or should I go?

This brings me to the final leg of the proverbial stool, the trade spat between China and the U.S. Indeed, this seems to be the most important factor at the moment, at least based on the fact that the robot traders buy the market on positive trade headlines and do the opposite when the news on the situation is negative.

All of this makes me wonder if we are not witnessing a mirror image/complete reversal of the October bear market, especially since last week started on a down note but the “buy the dip” crowd resurfaced in a big way. Indeed, the only thing we know so far is that there has been aggressive money flow into iShares NASDAQ Biotechnology Index (IBB) and the semiconductor stocks such as Texas Instruments (TXN), Applied Materials (AMAT), and Micron Technology (MU), which hit the afterburners last week.

Stuck in the Middle No More

Nowhere was the market’s indecision and tendency toward volatility more visible last week than in the activity of the New York Stock Exchange Advance Decline line (NYAD), which has had an uncanny ability to predict the general trend of the market since the 2016 presidential election.

chart 1
 

As the NYAD chart shows, activity that had been range bound led to a breakout to the up side as the 200-day moving average for NYAD has now become support rather than resistance. If this particular technical factor is not reversed, the odds favor higher stock prices over the next few weeks and perhaps longer.

Momentum Reversal for Indexes

Both the S&P 500 (SPX) and the Nasdaq 100 (NDX) reversed the weakness they displayed early last week and closed just below their recent January 2019 highs.

chart 2

Both indexes have crossed above their 50-day moving averages and seem to be setting up for a test of their 200-day moving averages. However, the Accumulation Distribution (ADI) and On Balance Volume (OBV) indicators suggest that money is moving aggressively back into the market. This confirms the positive action in the NYAD.

chart 3

Thus, until proven otherwise, the burden of proof has once again shifted to the bears as the algos and the hedge funds seem once again to be buying every dip.

Go with the Flow and Trade in Short Bursts

In this market the trading action is more than ever dependent on headlines and the way robot traders respond to those headlines. This is a mixed blessing of sorts as it creates volatility on an intraday basis and volatility creates opportunities for the nimble. But taking a more macro perspective, it’s clear that the algos will accelerate the major trend in the market. And that trend, at the moment, is up.

I own EWM, EWA, and EWZ as of this writing.